Marion G. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marion G. Miller has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
B. S. Winder
Department of Environmental Toxicology, One Shields Avenue, University of California, Davis, California 95616, USA
1 shared publicationC. S. Strandgaard
Department of Environmental Toxicology, One Shields Avenue, University of California, Davis, California 95616
1 shared publicationJunghee Lim
Department of Environmental Toxicology, University of California, Davis 95616, USA
1 shared publicationKaren Bozak Jelks
Department of Environmental Toxicology, University of California, One Shields Avenue, Davis, California 95616, USA
1 shared publication
Latest Publications
- 4 January 2007
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (2) , 540-545
Environmental Metabolomics: A SWOT Analysis (Strengths, Weaknesses, Opportunities, and Threats)
Metabolomic approaches have the potential to make an exceptional contribution to understanding how chemicals and other environmental stressors can affect both human and environmental health. However, the application of metabolomics to environmental exposures, although getting underway, has not yet been extensively explored. This review will use a SWOT analysis model to discuss some of the strengths, weaknesses, opportunities, and threats that are apparent to an investigator venturing into this relatively new field. SWOT has been used extensively in business settings to uncover new outlooks and identify problems that would impede progress. The field of environmental metabolomics provides great opportunities for discovery, and this is recognized by a high level of interest in potential applications. However, understanding the biological consequence of environmental exposures can be confounded by inter- and intra-individual differences. Metabolomic profiles can yield a plethora of data, the interpretation of which is complex and still being evaluated and researched. The development of the field will depend on the availability of technologies for data handling and that permit ready access metabolomic databases. Understanding the relevance of metabolomic endpoints to organism health vs adaptation vs variation is an important step in understanding what constitutes a substantive environmental threat. Metabolomic applications in reproductive research are discussed. Overall, the development of a comprehensive mechanistic-based interpretation of metabolomic changes offers the possibility of providing information that will significantly contribute to the protection of human health and the environment. Keywords: metabolomics • environment • susceptibility indicators • biomarkers • reproduction
- 4 January 2007
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (2) , 540-545
Environmental Metabolomics: A SWOT Analysis (Strengths, Weaknesses, Opportunities, and Threats)
Metabolomic approaches have the potential to make an exceptional contribution to understanding how chemicals and other environmental stressors can affect both human and environmental health. However, the application of metabolomics to environmental exposures, although getting underway, has not yet been extensively explored. This review will use a SWOT analysis model to discuss some of the strengths, weaknesses, opportunities, and threats that are apparent to an investigator venturing into this relatively new field. SWOT has been used extensively in business settings to uncover new outlooks and identify problems that would impede progress. The field of environmental metabolomics provides great opportunities for discovery, and this is recognized by a high level of interest in potential applications. However, understanding the biological consequence of environmental exposures can be confounded by inter- and intra-individual differences. Metabolomic profiles can yield a plethora of data, the interpretation of which is complex and still being evaluated and researched. The development of the field will depend on the availability of technologies for data handling and that permit ready access metabolomic databases. Understanding the relevance of metabolomic endpoints to organism health vs adaptation vs variation is an important step in understanding what constitutes a substantive environmental threat. Metabolomic applications in reproductive research are discussed. Overall, the development of a comprehensive mechanistic-based interpretation of metabolomic changes offers the possibility of providing information that will significantly contribute to the protection of human health and the environment. Keywords: metabolomics • environment • susceptibility indicators • biomarkers • reproduction
- Open Access
- 1 July 2001
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 62 (1) , 115-123
-Chlorohydrin Inhibits Glyceraldehyde-3-Phosphate Dehydrogenase in Multiple Organs as Well as in Sperm
Numerous studies have documented inhibitory effects of α-chlorohydrin (ACH) on glyceraldehyde-3-phosphate dehydrogenase (G3PDH) activity in spermatozoa. A sperm-specific G3PDH isoform has been described. The possibility that ACH may inhibit G3PDH in cell types other than sperm was investigated in this work. In addition, the onset of ACH-induced epididymal toxicity was described. Changes to epididymal histology occurred 6 h following a single dose of ACH (50 mg/kg po) and were confined to the proximal initial segment. By 24 h, no epithelial cells lined the basement membrane of that region. Three h after ACH administration (50 mg/kg po), G3PDH activity was significantly decreased in sperm (85%) as well as in kidney (31%), liver (49%), and epididymis (35%). Enzyme activity remained inhibited at 6 and 24 h. G3PDH was immunolocalized in the epididymis and staining was highest in the efferent ducts and initial segment as well as in smooth muscle. Since G3PDH is a microtubule-associated protein and microtubule-dependent endocytosis occurs in the epididymis, β-tubulin was also immunolocalized. β-tubulin densely stained the apical region of initial segment and caput epithelial cells. Disruption of β-tubulin immunostaining correlated with the localization and onset of the lesion. Co-localization of G3PDH and β-tubulin immunostaining was not observed although both antibodies most densely stained the initial segment. Our data indicate that histologic changes to the proximal initial segment of the epididymis occur rapidly, but subsequent to G3PDH inhibition. Moreover, ACH inhibition of G3PDH is not confined to sperm, although the sperm enzyme is most sensitive to inhibition.
- 1 July 2001
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 62 (1) , 115-123
Open Access-Chlorohydrin Inhibits Glyceraldehyde-3-Phosphate Dehydrogenase in Multiple Organs as Well as in Sperm
Numerous studies have documented inhibitory effects of α-chlorohydrin (ACH) on glyceraldehyde-3-phosphate dehydrogenase (G3PDH) activity in spermatozoa. A sperm-specific G3PDH isoform has been described. The possibility that ACH may inhibit G3PDH in cell types other than sperm was investigated in this work. In addition, the onset of ACH-induced epididymal toxicity was described. Changes to epididymal histology occurred 6 h following a single dose of ACH (50 mg/kg po) and were confined to the proximal initial segment. By 24 h, no epithelial cells lined the basement membrane of that region. Three h after ACH administration (50 mg/kg po), G3PDH activity was significantly decreased in sperm (85%) as well as in kidney (31%), liver (49%), and epididymis (35%). Enzyme activity remained inhibited at 6 and 24 h. G3PDH was immunolocalized in the epididymis and staining was highest in the efferent ducts and initial segment as well as in smooth muscle. Since G3PDH is a microtubule-associated protein and microtubule-dependent endocytosis occurs in the epididymis, β-tubulin was also immunolocalized. β-tubulin densely stained the apical region of initial segment and caput epithelial cells. Disruption of β-tubulin immunostaining correlated with the localization and onset of the lesion. Co-localization of G3PDH and β-tubulin immunostaining was not observed although both antibodies most densely stained the initial segment. Our data indicate that histologic changes to the proximal initial segment of the epididymis occur rapidly, but subsequent to G3PDH inhibition. Moreover, ACH inhibition of G3PDH is not confined to sperm, although the sperm enzyme is most sensitive to inhibition.
- Open Access
- 1 January 2001
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 59 (1) , 138-146
The Role of GTP Binding and Microtubule-Associated Proteins in the Inhibition of Microtubule Assembly by Carbendazim
The fungicide carbendazim (CBZ) is known to disrupt microtubular structures in the testis and to cause testicular toxicity in rats. To investigate the mechanism underlying the toxicity of CBZ, tubulin and microtubule-associated proteins (MAPs) were isolated from rat testis and brain using two techniques. The effects of CBZ on MT assembly were compared with the known microtubule (MT) disruptors, colchicine and nocodazole. CBZ (100 μM) had no effect on the assembly of MTs from MAP-containing tubulin isolated with one cycle of glycerol-dependent assembly and disassembly while colchicine (40 μM) and nocodazole (12.5 μM) strongly inhibited the assembly reaction. Similarly, formation of MTs from tubulin prepared with two cycles of glycerol-dependent assembly was strongly inhibited by colchicine and nocodazole but only weakly by CBZ. All three compounds inhibited the assembly of MTs from MAP-free tubulin isolated with glutamate. However, the inhibition by CBZ was reversed by the inclusion of high-molecular-weight MAPs and not by unrelated protein (bovine serum albumin, BSA). Addition of nocodazole to assembled MTs caused immediate depolymerization, whereas CBZ did not directly cause depolymerization. However CBZ was an effective inhibitor of the polymerization of depolymerized tubulin. In competitive binding assays, CBZ was found to inhibit the binding of guanosine triphosphate (GTP) to tubulin. The data suggest that CBZ interferes with initial events of MT polymerization, specifically GTP binding, and that MAPs moderate this effect.
- 1 January 2001
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 59 (1) , 138-146
Open AccessThe Role of GTP Binding and Microtubule-Associated Proteins in the Inhibition of Microtubule Assembly by Carbendazim
The fungicide carbendazim (CBZ) is known to disrupt microtubular structures in the testis and to cause testicular toxicity in rats. To investigate the mechanism underlying the toxicity of CBZ, tubulin and microtubule-associated proteins (MAPs) were isolated from rat testis and brain using two techniques. The effects of CBZ on MT assembly were compared with the known microtubule (MT) disruptors, colchicine and nocodazole. CBZ (100 μM) had no effect on the assembly of MTs from MAP-containing tubulin isolated with one cycle of glycerol-dependent assembly and disassembly while colchicine (40 μM) and nocodazole (12.5 μM) strongly inhibited the assembly reaction. Similarly, formation of MTs from tubulin prepared with two cycles of glycerol-dependent assembly was strongly inhibited by colchicine and nocodazole but only weakly by CBZ. All three compounds inhibited the assembly of MTs from MAP-free tubulin isolated with glutamate. However, the inhibition by CBZ was reversed by the inclusion of high-molecular-weight MAPs and not by unrelated protein (bovine serum albumin, BSA). Addition of nocodazole to assembled MTs caused immediate depolymerization, whereas CBZ did not directly cause depolymerization. However CBZ was an effective inhibitor of the polymerization of depolymerized tubulin. In competitive binding assays, CBZ was found to inhibit the binding of guanosine triphosphate (GTP) to tubulin. The data suggest that CBZ interferes with initial events of MT polymerization, specifically GTP binding, and that MAPs moderate this effect.
- Open Access
- 1 June 1997
- Published by Elsevier in Fundamental and Applied Toxicology
- Vol. 37 (2) , 158-167
Role of Testis Exposure Levels in the Insensitivity of Prepubertal Rats to Carbendazim-Induced Testicular Toxicity,
- 1 June 1997
- Published by Elsevier in Fundamental and Applied Toxicology
- Vol. 37 (2) , 158-167
Open AccessRole of Testis Exposure Levels in the Insensitivity of Prepubertal Rats to Carbendazim-Induced Testicular Toxicity,